Myelodysplastic Syndrome Lawsuit Settlement

Myelodysplastic Syndrome (MDS) is a blood disorder characterized by low blood cell counts. It often precedes acute myelogenous leukemia.

It can affect bone marrow as well as blood cells. There may be fewer white blood cells or red blood cells. platelets.

MDS patients can survive with treatment, chemo or stem-cell transplant. Multiple studies have linked exposure to TCE and PCE at Camp Lejeune to MDS.

Compensation

Myelodysplastic Syndrome, or MDS is when immature blood cells in bone marrow don't develop into healthy ones. This causes the body's red and white blood cells to decrease as do platelets that help to clot blood. The symptoms of MDS include fatigue, weakness or weight loss and bone pain. It may also result in a lower-than-normal number of blood cells, which can lead to severe anemia. Other symptoms include unusual bruising and bleeding (a indication of low platelet counts), frequent infections, and pinpoint sized red spots on the skin that are caused by bleeding under the skin's surface (petechiae).

MDS is not cancerous but it can progress into leukemia. It is difficult to treat.

The Camp Lejeune justice act allows individuals who lived or worked on the Marine Corps Base Camp Lejeune between 1953 until 1987 for at least 30 consecutive days to file a lawsuit in the event that they were diagnosed with a Myelodysplastic Syndrome injury settlements disorder or other blood disorders that are linked to benzene.

Every case of MDS or any other myelodysplastic disorder is unique and is unique to the genes and the molecules that cause the disease. OSUCCC James experts, including subspecialists, hematologists and other specialists, apply their knowledge to create an individualized treatment plan. This could include chemotherapy, stem cell or bone marrow transplants, blood transfusions, or access to clinical trials right here in the hospital.

Damages

Myelodysplastic syndromes (MDS) are a class of disorders that affect blood-forming cells in the bone marrow. These abnormal cells block the growth of healthy blood cells and can result in a shortage of red blood cells (anemia), platelets (thrombocytopenia), or white blood cells (leukopenia).

MDS is usually treated by increasing blood counts through stem cell transplants, bone marrow transplant and blood-cell growth factors and chemotherapy. Treatment is individualized to the individual's needs and is based on the type of MDS.

Compensation for victims of myelodysplastic Syndrome can include medical bills, Myelodysplastic Syndrome Lawsuit lost earnings and future financial needs. Victims may also be compensated for mental distress and other non-economic damages.

In July 2011, the deceased started seeing the defendant hematologist for anemia that had an unknown etiology. The hematologist said that it could be early Myelodysplastic Syndrome injury settlements syndrome, but did not perform an marrow bone biopsy, instead opting for monitoring and stating she would perform the procedure if there were more drops in his hematocrit.

Benzene is a known carcinogen that is a probable cause of myelodysplastic syndrome and other cancers. Railroad workers are particularly at risk of developing Myelodysplastic Syndrome cancer settlement syndrome and other cancers because they are frequently exposed to benzene while working. Joe Lyon is a highly rated Toxic Tort Lawyer reviewing benzene exposure and related myelodysplastic disorder lawsuits for individuals across the country.

Time for Litigation

The number of claims will determine the length of time required to settle the myelodysplastic Syndrome lawsuits. The Congressional Budget Office, a flawed bureaucracy that is the most accurate at forecasting costs, has forecast the total settlement amount to be $22 billion.

Victims are seeking reimbursement for medical bills as well as lost income due to the absence of work hours due to treatment. The families of the victims seek compensation for the emotional trauma caused to them by the disease.

Our lawyers are looking into cases of railroad workers for Myelodysplastic Syndrome cancer settlements disorder, leukemia, and other diseases that may be presumptively related to workplace benzene. Fill out our online form if you have developed cancer or a different disease while working on the railway. We will assess your claim right away and at no cost.

Attorney Fees

Under the Camp Lejeune Justice Act, those who lived or worked at the base from 1953 to 1987 has the right to start a lawsuit. This includes those who have developed myelodysplastic syndrome (MDS) or other blood cancers as a result of exposure to the water that was contaminated.

Myelodysplastic Syndrome occurs when abnormal blood-forming cells in bone marrow are not functioning properly, resulting in low blood cell counts. The condition can progress to acute myeloidleukemia which is a more serious form of bone marrow tumor.

The symptoms include feeling of feeling tired, having shortness of breath, and pale skin. A peripheral blood smear could show changes in the quantity and type of red blood cells and white blood cells and platelets. These tests can help doctors identify the myelodysplastic disorder and determine the best treatment.

MDS is treated with chemotherapy and blood transfusions. Stem cell transplants are a further alternative. It is also necessary to be aware of the condition and determine if it worsens or becomes more severe. The treatment for myelodysplastic syndrome is based on the type of MDS and, sometimes, patients are treated for multiple forms at once. Learn more about Myelodysplastic Syndrome injury settlement disorder and other blood cancers, by visiting the PDQ cancer information summary from the National Institutes of Health. This website provides up-to-date, accurate cancer information and is designed to assist you in making decisions about your health.